{
  "url": "https://openlegislation.uk/medicines-sale-or-supply-miscellaneous-provisions-amendment-regulations-2001/regulation-2",
  "json_url": "https://openlegislation.uk/medicines-sale-or-supply-miscellaneous-provisions-amendment-regulations-2001/regulation-2.json",
  "legislation": "uksi/2001/3849",
  "legislation_title": "The Medicines (Sale or Supply) (Miscellaneous Provisions) Amendment Regulations 2001",
  "legislation_url": "https://openlegislation.uk/medicines-sale-or-supply-miscellaneous-provisions-amendment-regulations-2001",
  "path": "regulation/2",
  "kind": "regulation",
  "number": "2",
  "heading": "Amendment of regulation 8 of the Medicines (Sale or Supply) (Miscellaneous Provisions) Regulations 1980",
  "text": "In regulation 8 of the Medicines (Sale or Supply) (Miscellaneous Provisions) Regulations 1980 (pack size on retail sale or supply of certain medicinal products on a general sale list)—\n(a) in paragraph (1), for “paragraphs (2) to (2I) and (3)” there is substituted “paragraphs (2) to (2L) and (3)”;\n(b) in paragraph (2), for sub-paragraph (b) there is substituted—\n“(b) in the case of tablets that are not effervescent—\n(i) where they are enteric-coated, contain aspirin only, and the amount of aspirin in each tablet does not exceed 75 milligrams, not more than 28 tablets,\n(ii) where they contain aloxiprin, or aspirin or paracetamol or a combination of any or all of those substances, and do not satisfy the conditions specified in head (i) of this sub-paragraph, not more than 16 tablets;”;\n(c) in paragraph (2B) after sub-paragraph (d) add the following sub-paragraph—\n“(e) in the case of liquid preparations of ibuprofen, individual unit doses of not more than 5 millilitres each to a maximum of 20 unit doses.”; and\n(d) after paragraph (2I) there are inserted the following paragraphs—\n“(2J) Where a medicinal product for human use containing cetirizine hydrochloride is sold by retail in the course of a business elsewhere than at a registered pharmacy or is so offered or exposed for sale by retail or so supplied in circumstances corresponding to retail sale, the product shall be presented for sale in a separate and individual container or package containing not more than 7 tablets.\n(2K) Where a medicinal product for human use containing loratadine is sold by retail in the course of a business elsewhere than at a registered pharmacy or is so offered or exposed for sale by retail or so supplied in circumstances corresponding to retail sale, the product shall be presented for sale in a separate and individual container or package containing not more than 7 tablets.\n(2L) Where a medicinal product for human use containing ibuprofen lysine is sold by retail in the course of a business elsewhere than at a registered pharmacy or is so offered or exposed for sale by retail or so supplied in circumstances corresponding to retail sale, the product shall be presented for sale in a separate and individual container or package containing not more than 16 tablets.”.",
  "extent": "E+W+S+NI",
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "footnote",
      "label": "f1",
      "text": "S.I. 1980/1923; relevant amending instruments are S.I. 1982/28, 1990/1124, 1994/2411, 1995/3215, 1997/2045, 1999/644 and 2510, and 2000/1070, 1918 and 2494."
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2001/3849/regulation/2",
    "retrieved_at": "2026-10-29T07:20:41.914461+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}